ssea1 Search Results


mc  (Developmental Studies Hybridoma Bank)
93
Developmental Studies Hybridoma Bank mc
Mc, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mc/product/Developmental Studies Hybridoma Bank
Average 93 stars, based on 1 article reviews
mc - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
cell separation  (Miltenyi Biotec)
95
Miltenyi Biotec cell separation
Cell Separation, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell separation/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cell separation - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
3164001b  (fluidigm)
93
fluidigm 3164001b

3164001b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3164001b/product/fluidigm
Average 93 stars, based on 1 article reviews
3164001b - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
pacific blue  (Miltenyi Biotec)
95
Miltenyi Biotec pacific blue

Pacific Blue, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pacific blue/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
pacific blue - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
nestin  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc nestin
Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence <t>of</t> <t>CD133</t> and <t>NESTIN</t> in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001
Nestin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nestin/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
nestin - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
cd15 ssea1 mc480 mouse mab  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc cd15 ssea1 mc480 mouse mab
Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence <t>of</t> <t>CD133</t> and <t>NESTIN</t> in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001
Cd15 Ssea1 Mc480 Mouse Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd15 ssea1 mc480 mouse mab/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
cd15 ssea1 mc480 mouse mab - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
cd15  (Miltenyi Biotec)
97
Miltenyi Biotec cd15
Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence <t>of</t> <t>CD133</t> and <t>NESTIN</t> in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001
Cd15, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd15/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
cd15 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier
anti ssea1 antibody  (Santa Cruz Biotechnology)
95
Santa Cruz Biotechnology anti ssea1 antibody
Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence <t>of</t> <t>CD133</t> and <t>NESTIN</t> in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001
Anti Ssea1 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ssea1 antibody/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
anti ssea1 antibody - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
dh • mc 480  (Developmental Studies Hybridoma Bank)
91
Developmental Studies Hybridoma Bank dh • mc 480
Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence <t>of</t> <t>CD133</t> and <t>NESTIN</t> in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001
Dh • Mc 480, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dh • mc 480/product/Developmental Studies Hybridoma Bank
Average 91 stars, based on 1 article reviews
dh • mc 480 - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
ssea  (Miltenyi Biotec)
95
Miltenyi Biotec ssea
Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence <t>of</t> <t>CD133</t> and <t>NESTIN</t> in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001
Ssea, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ssea/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
ssea - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
vimc6 130 114 008 miltenyi biotec  (Miltenyi Biotec)
95
Miltenyi Biotec vimc6 130 114 008 miltenyi biotec
Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence <t>of</t> <t>CD133</t> and <t>NESTIN</t> in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001
Vimc6 130 114 008 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vimc6 130 114 008 miltenyi biotec/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
vimc6 130 114 008 miltenyi biotec - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


Journal: eLife

Article Title: Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study

doi: 10.7554/eLife.78921

Figure Lengend Snippet:

Article Snippet: Antibody , CD15 (164Dy, Human, monoclonal) , Fluidigm , 3164001B , 1:1000.

Techniques: Sequencing

Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence of CD133 and NESTIN in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001

Journal: Journal of translational medicine

Article Title: The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.

doi: 10.1186/s12967-023-04740-0

Figure Lengend Snippet: Fig. 6 MAD2L2 affects the stemness of glioma cells. A In the MAD2L2 high-expression group, all six different stemness scores are higher compared to the low-expression group. B GSEA analysis demonstrates that MAD2L2 is associated with the activation of glioblastoma stem cell pathways. C The expression of MAD2L2 is higher in stem cells compared to non-stem cells. D Immunofluorescence of CD133 and NESTIN in U87-derived glioblastoma stem cells. E After MAD2L2 knockdown, the sphere-forming ability of glioblastoma stem cells is reduced. Conversely, when MAD2L2 is overexpressed, the sphere-forming ability of glioblastoma stem cells is enhanced. F, G MAD2L2 knockdown downregulated the protein levels of stemness biomarkers, while MAD2L2 overexpression upregulated them. *P < 0.05, **P < 0.01, ***P < 0.001

Article Snippet: Diluted primary antibodies to CD133 (#64326S, Cell Signaling Technology), Nestin (#89529S, Cell Signaling Technology) and CD15 (#74180SF, Cell Signaling Technology) were added to the GSCs, followed by overnight incubation in a wet box at 4 °C.

Techniques: Expressing, Activation Assay, Immunofluorescence, Derivative Assay, Knockdown, Over Expression